Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6,38% | 0 | 64,66% | 2,75% | 2050-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5,85% | 0 | 82,60% | 4,00% | 2045-11-20 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5,67% | 10 K | 82,55% | 3,70% | 2042-09-21 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5,58% | 0 | 88,95% | 4,40% | 2044-05-06 | 1,85 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5,54% | 3 M | 90,60% | 4,70% | 2054-09-18 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5,11% | 6,87 M | 94,05% | 4,20% | 2034-09-18 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 5,01% | 0 | 87,49% | 2,20% | 2030-08-14 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4,85% | 3,51 M | 95,65% | 4,00% | 2031-09-18 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAP3NOVARTIS CAP 20/25 | 4,83% | 0 | 99,30% | 1,75% | 2025-02-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4,82% | 0 | 98,27% | 3,00% | 2025-11-20 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4,69% | 2,25 M | 96,51% | 3,80% | 2029-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4,59% | 0 | 96,68% | 3,10% | 2027-05-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 4,54% | 271 K | 94,86% | 2,00% | 2027-02-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3,52% | 0 | 83,18% | 1,70% | 2038-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 2,80% | 0 | 92,96% | 1,38% | 2030-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2,77% | 0 | 90,41% | 0,00% | 2028-09-23 | 1,85 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2,42% | 0 | 93,70% | 0,63% | 2028-09-20 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2,32% | 0 | 96,79% | 1,13% | 2027-09-30 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2,30% | 0 | 98,74% | 1,63% | 2026-11-09 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
CH135325783NOVARTIS 24/40 | 0,96% | 0 | 112,11% | 1,85% | 2040-06-18 | 280 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH27019100NOVARTIS AG 15-35 | 0,95% | 0 | 100,96% | 1,05% | 2035-05-11 | 325 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH135325784NOVARTIS 24/49 | 0,93% | 0 | 118,53% | 1,85% | 2049-06-18 | 190 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH135325782NOVARTIS 24/34 | 0,87% | 0 | 107,77% | 1,75% | 2034-06-16 | 645 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
NOTCNOVARTIS AG 15-29 | 0,80% | 0 | 99,16% | 0,63% | 2029-11-13 | 550 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
A3LZ2RNOVARTIS INC 2024-18.06.31 REG S | 0,75% | 0 | 105,64% | 1,65% | 2031-06-18 | 435 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH135325780NOVARTIS 24/27 | 0,64% | 0 | 102,42% | 1,60% | 2027-06-18 | 650 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
NOTBNOVARTIS AG 15-25 | 0,64% | 0 | 99,82% | 0,25% | 2025-05-13 | 500 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |